Absolute Bioavailability Study With Bexagliflozin

Stopped Sponsor decision to not initiate study due to sufficient bioavailability information

Conditions

• Type 2 Diabetes Mellitus

Interventions

• DRUG: Bexagliflozin

Sponsor

Theracos